Cargando…
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
Carbonic anhydrase-IX (CA-IX) is attracting much attention as a target molecule for cancer treatment since high expression of CA-IX can lead to a poor prognosis of patients. We previously reported low-molecular-weight (111)In/(90)Y complexes with a bivalent ureidosulfonamide scaffold ([(111)In/(90)Y...
Autores principales: | Iikuni, Shimpei, Watanabe, Hiroyuki, Shimizu, Yoichi, Nakamoto, Yuji, Ono, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725290/ https://www.ncbi.nlm.nih.gov/pubmed/33296398 http://dx.doi.org/10.1371/journal.pone.0243327 |
Ejemplares similares
-
Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018) -
Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021) -
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
por: Riemann, Anne, et al.
Publicado: (2018) -
Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
por: Shimizu, Yoichi, et al.
Publicado: (2021) -
Novel Bivalent (99m)Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy
por: Iikuni, Shimpei, et al.
Publicado: (2016)